MGMA 2025 data puts median orthopedic surgeon total compensation at $703,000 against a median of 8,812 wRVUs. The benchmark is a starting point. The plan design is where most groups make expensive mistakes.
Key Takeaways
- MGMA 2025 data reports median orthopedic surgeon total compensation of $703,000 at a median of 8,812 wRVUs, implying a median conversion factor around $79.78 per wRVU – subspecialty variation is wide, with spine at $820,000 and total joint at $904,000.
- The conversion factor is the single most important number in a wRVU plan, and it is the one most groups set once and never revisit – even as CMS adjusts the relative values underlying the wRVUs and the practice’s cost structure changes.
- Plans that separate clinical compensation from ancillary and call coverage income work better in practice than those that bundle everything into the wRVU rate, because they make each income component transparent and separately negotiable.
- The governance failures that generate partner disputes are almost always plan-design failures: productivity thresholds set without modeling their effect, conversion factors that create unintended windfalls, and no defined process for annual review.
Physician compensation in orthopedics is more data-rich than in most specialties, and the data is also more dangerous if you use it without understanding what it measures. MGMA’s 2025 Provider Compensation and Productivity Data Report puts median total compensation for orthopedic surgeons at approximately $703,000, against a median productivity of 8,812 work relative value units and an implied conversion factor around $79.78 per wRVU. Subspecialty figures vary substantially: spine trends toward $820,000, total joint replacement toward $904,000, and sports medicine encompasses a wide range depending on surgical versus non-surgical focus. These are the benchmarks most compensation conversations start with.
The problem with using MGMA benchmarks as a compensation plan is that they describe outcomes, not designs. A group that sets its conversion factor to produce the median compensation for physicians at the median wRVU production has built a plan that pays correctly for one point on the productivity distribution and incorrectly for everything above and below it. High producers are often undercompensated relative to what their marginal revenue would support; low producers are often subsidized without the plan making that subsidy explicit. Both conditions create resentment, and resentment in orthopedic partnerships surfaces in ways that are expensive to resolve.
The right starting point is not the benchmark. It is your practice’s actual economics: what does a marginal wRVU actually produce in net revenue, given your specific payer mix, your overhead structure, and your ancillary revenue allocation? That number is the upper bound on a sustainable conversion factor. The MGMA figure is useful context – it tells you whether what you can afford to pay is competitive in the market – but it does not tell you what you can afford to pay, and conflating the two is how groups build compensation plans that work on paper and create cash flow problems in practice.
The Conversion Factor: One Number, Most of the Risk
The conversion factor in a wRVU compensation plan is the dollar amount paid per work RVU produced. If a surgeon performs a primary total knee replacement, CMS assigns that procedure a wRVU value. Multiply that value by the conversion factor and you have the surgical component of that surgeon’s compensation for the procedure. It sounds mechanical because it is – which is exactly the appeal. The plan pays for output without requiring subjective judgment about who worked harder.
What the mechanism obscures is that the wRVU values CMS assigns to procedures are updated annually, and not always in directions that are favorable to orthopedic surgeons. CMS has historically adjusted high-value surgical codes downward over time as it revalues the relative work involved. A conversion factor set five years ago against the then-current wRVU values is producing a different compensation outcome today, even if neither the factor nor the physician’s surgical volume has changed. Groups that set conversion factors once and review them never have almost always introduced distortions they did not intend.
The discipline is to re-model the plan annually: update the wRVU values for your top twenty procedure codes, compute what the current conversion factor implies for physicians at the 25th, 50th, and 75th percentile of group productivity, and compare those implied pay levels to current MGMA benchmarks. If the implied compensation is drifting away from market – either too high to be sustainable or too low to be competitive – you need to know before it shows up in a physician departure or a cash flow crisis.
The conversion factor is set once at most practices and reviewed never. CMS updates wRVU values every year. The gap between what you intended to pay and what you are paying widens silently until somebody does the math.
Threshold Structures and What They Actually Incentivize
Most wRVU plans in orthopedics use some form of threshold: a minimum productivity level below which a different (usually lower) rate applies, and sometimes a tiered rate that increases above a higher threshold. Thresholds make sense in theory – they protect the practice against paying out above what a low-producer generates, and they reward the high producer – but they create behavioral distortions that are predictable and frequently overlooked at plan design.
A physician who is 200 wRVUs below the threshold in October will slow down elective case scheduling to avoid the awkwardness of falling into the lower tier. A physician who is 300 wRVUs above the upper threshold in September will stop scheduling elective cases until January rather than produce work that earns at a lower marginal rate. Neither behavior serves the practice, and both are rational responses to the plan as designed. The solution is not to eliminate thresholds but to model the behavioral implications at the extremes before setting them. Run the plan forward on each physician’s historical production and ask where the plan creates the wrong incentive. Those are the points to redesign.
Separating the Components: Clinical, Call, and Ancillary
The cleanest compensation plans are those that pay separately for each type of contribution: a wRVU-based rate for clinical production, an explicit dollar amount for call coverage, and a defined mechanism for allocating ancillary income. Bundling all three into the wRVU rate seems simpler but creates opacity that generates disputes. If call coverage is implicit in the conversion factor rather than explicit, you cannot renegotiate the call arrangement without renegotiating the entire compensation plan. If ancillary income is distributed based on wRVU productivity, you have created an indirect link between referrals and income that may or may not pass Stark scrutiny depending on how it is structured – and the structure should be reviewed by counsel rather than assumed to be compliant.
The governance process around compensation is as important as the plan itself. A compensation plan without a defined annual review cycle, a defined process for raising disputes, and defined metrics for evaluating whether the plan is working is a governance failure waiting to happen. Most orthopedic partnership disputes that reach the level of legal action involve compensation grievances that were visible for eighteen months before anyone addressed them formally. Build the review process into the plan document, not into the hope that partners will raise issues when they have them.
From the Field
A six-physician orthopedic group in the Mountain West had operated on the same wRVU conversion factor for four years. The senior partners believed the plan was working; two mid-level producers had grown quietly dissatisfied and were fielding outside offers. A compensation modeling exercise found the source: CMS had reduced wRVU values for several high-volume shoulder and knee codes over those four years while simultaneously the practice’s overhead had increased, compressing the effective margin per wRVU. The senior partners were above the productivity threshold where the original factor was set, and the plan was still working adequately for them. The mid-level producers were in the band where the compression was most acute. Our fractional CFO engagement rebuilt the plan model, updated the wRVU values, reset the conversion factor on a defensible economic basis, separated call pay from the production rate, and installed a semi-annual production review. The plan was restructured without a partner vote becoming adversarial, and both mid-level producers stayed.
Advice Versus Plan Design
A compensation consultant can build the model, benchmark the outcomes, identify the distortions, and hand you a redesigned plan. If your administrator has experience running compensation calculations and your partners can engage with a plan document without the conversation becoming political, that is often the right scope of engagement. Consulting is not a lesser service; it is the right service for a practice with the internal capacity to execute the plan once it is designed.
The situations that benefit from a fractional executive are those where the plan needs to be rebuilt and then run for two or three cycles while the practice builds internal competency, or where the plan redesign is politically charged enough that an outside operator running the monthly production reviews adds a neutrality that the administrator cannot provide. In either case, the fractional work is specific: pulling the wRVU data from the practice management system each month, computing each physician’s payment, preparing the production summary, and running the quarterly review meeting until the process becomes routine. That is administration, not consulting, and it happens inside the practice’s systems with the practice’s data.
“Fractional executive” is an unregulated designation, and some firms apply it to monthly report delivery without any of the embedded operational work described above. Before you engage anyone for this scope, ask specifically: will they work inside your EMR and practice management system, or will they receive data exports and return reports? The answer tells you which service you are buying.
Sources
- MGMA, 2025 Provider Compensation and Productivity Data Report — https://www.mgma.com/2025-provider-compensation
- CMS, Transforming Episode Accountability Model (TEAM), January 2026 — https://www.cms.gov/priorities/innovation/media/document/bpcia-my7-rfa
- Stout, 2026 Industry Outlook: Orthopedic Practices and Ancillary Services — https://www.stout.com/en/insights/industry-update/2026-industry-outlook-orthopedic-practices-ancillary-services
- MedPAC, Ambulatory Surgical Center Services: Status Report, March 2025 — https://www.medpac.gov/wp-content/uploads/2025/03/Mar25_Ch10_MedPAC_Report_To_Congress_SEC.pdf
More in the Orthopedics Series
- Building Ancillary Revenue in Orthopedics: Imaging, PT, and ASC — the ancillary revenue model that adds durable income without adding clinical hours.
- Payer Contracting in Orthopedics: Fee Schedules, Bundles, and TEAM — what your commercial contracts actually pay and how the mandatory TEAM bundled model changes the math.
- The PE Offer in Orthopedics: What to Evaluate Before You Sign — the framework for evaluating a PE offer against a credible independence plan.
- Block Time and Clinic Flow: The Throughput Problem Most Orthopedic Groups Ignore — the scheduling and block time changes that increase surgical volume without adding a surgeon.